Amgen Gets FTC Green Light On $28B Horizon Deal
The Federal Trade Commission said Friday it has reached a deal with pharmaceutical giant Amgen Inc. that will allow the company to proceed with its $27.8 billion purchase of Horizon Therapeutics...To view the full article, register now.
Already a subscriber? Click here to view full article